Trinity Resources, Inc. engages in the exploration and development of natural resource interests. The company is headquartered in Henderson, Nevada. The company went IPO on 2001-07-11. The firm is engaged in research and development targeting treatments of brain diseases. The company is also focused on chemical development of its new drugs dedicated to the symptomatic treatment of Alzheimer’s Disease but can be applied to other neurological diseases due to its platform technology.
TRRI stock price ended at $0 on 星期二, after rising NaN%
On the latest trading day Jul 14, 2026, the stock price of TRRI rose by NaN%, climbing from $0.00 to $0.00. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $0.00 and a high of $0.00. Notably, trading volume dropped by 1 shares on the last day despite the price increase, which may signal a potential uptick in risk in the near term. A total of 334 shares were traded, equating to a market value of approximately --.
Comment les indicateurs d'analyse technique s'appliquent-ils à TRRI ?
Selon l'analyse technique, Alzex Neuropharma Inc a un signal agrégé de Buy. Alzex Neuropharma Inc a 3 signaux d'achat, 3 signaux neutres et 1 signaux de vente.
Quels sont les niveaux de retracement de Fibonacci pour TRRI ?
Le niveau de retracement de Fibonacci de Alzex Neuropharma Inc est 低於 100% 水準。
Quel est le RSI de Alzex Neuropharma Inc ?
Le RSI de Alzex Neuropharma Inc est actuellement de 22.22, indiquant une condition 超賣
Quel est le prix de Alzex Neuropharma Inc pour les 12 prochains mois ?
Le prix de Alzex Neuropharma Inc TRRI pour les 12 prochains mois est estimé à $0.
Jusqu'où Alzex Neuropharma Inc est-il attendu?
Selon les analystes de Wall Street, Alzex Neuropharma Inc devrait atteindre une prévision haute de $0.